Shandong First Medical University Researchers Identify Exosomal miR-122-3p as Key Driver of Metabolic Liver Disease

Shandong First Medical University researchers discover a microRNA pathway that drives liver steatosis, offering new non-invasive diagnostic and therapeutic targets.

By: AXL Media

Published: Apr 18, 2026, 4:30 AM EDT

Source: Information for this report was sourced from Chinese Medical Journals Publishing House Co., Ltd.

Molecular Signaling Transformed From Passive Cargo to Disease Driver

Research led by experts from Shandong First Medical University has uncovered a sophisticated intercellular communication system that drives the progression of metabolic liver disease. By isolating and characterizing exosomes—microscopic vesicles that transport genetic material between cells—the team identified specific microRNAs that serve as active signals for metabolic dysfunction. The study, published on March 16, 2026, in the Chinese Medical Journal, represents a significant shift in understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, or MASLD. Historically viewed through the lens of simple fat accumulation, the disease is now being reframed as a state of dysregulated genetic signaling mediated by circulating exosomes.

Differential Expression Profiling Isolates Key Pathogenic MicroRNAs

The investigative team utilized plasma samples from MASLD patients and healthy volunteers to conduct high-throughput miRNA expression profiling. Their analysis pinpointed two specific molecules, miR-122-3p and miR-3614-5p, which were significantly elevated in the bloodstream of those with the disease. Subsequent in vitro experiments using human liver cell lines demonstrated that only miR-122-3p possessed the ability to induce the hallmarks of MASLD, including the buildup of triglycerides and the production of reactive oxygen species. This distinction is critical, as it identifies a specific molecular culprit among the thousands of microRNAs circulating in the human body, providing a clear target for diagnostic development.

Engineered Exosomes Validate the Suppression of Protective Enzymes

To confirm the causal role of these genetic markers, the researchers utilized engineered exosomes to overexpress miR-122-3p in healthy liver cells. These synthetic vesicles successfully replicated the pathological effects seen in MASLD patients, specifically by suppressing the activity of adenosine 5'-monophosphate-activated protein kinase, known as AMPK. As a pivotal energy sensor, AMPK normally protects the liver by enhancing fatty acid oxidation and limiting the synthesis of new fats. The study revealed that miR-122-3p effectively "mutes" this protective enzyme, leaving hepatocytes vulnerable to lipid overload and oxidative damage, thereby accelerating the transition from simple steatosi...